Tali Digital Ltd (TD1)

TD1 Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

TD1's Principal Activity is the the launch of TALi TRAIN and the on-going development of TALi DETECT as part of TALi Digitals CRC-P grant project.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Dr David Lionel Brookes	Non-Executive Director	Jun 2020	Dr David Lionel Brookes Non-Executive Director Dr Brookes has experience in the health and biotechnology industries, becoming part of the biotechnology sector in the 1990's as an analyst. Dr Brookes has since held Board positions in a number of ASX listed biotechnology companies. He has also Chaired and been a Member of a number of risk and audit committees in ASX listed companies. He is currently a Non-Executive Chairman of the Better Medical group.
Mr Stephen (Steve) Denaro	Company Secretary	Feb 2019
Ms Sue MacLeman	Non-Executive Chairman,Non-Executive Director	Sep 2018	Ms Sue MacLeman Non-Executive Chairman,Non-Executive Director Ms MacLeman has over 30 years experience in the medtech, pharma and biotech sector and is currently Chair, Anatara Lifesciences Ltd, Chair MTPConnect Ltd, Non-Executive Director Oventus Medical Ltd and Non-Executive Director Palla Pharma Ltd and Veski Innovation.
Mr Glenn Smith	Managing Director	May 2018	Mr Glenn Smith Managing Director Mr Smith has over twenty years experience to led customer focus businesses in periods of growth.
Mr Jefferson Harcourt	Non-Executive Director	Feb 2016	Mr Jefferson Harcourt Non-Executive Director Mr Harcourt sits on a number of private technology company boards in the medical device and security markets.

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
27/11/20	David Brookes	Issued	3,400,000	$0.038	$129,200	Issue of securities
27/11/20	Glenn Smith	Issued	22,500,000	$0.038	$855,000	Issue of securities
22/09/20	Glenn Smith	Cancelled	14,377,766	$0.026	$373,821	Cancellation of securities
26/03/20	Sue MacLeman	Buy	+80,008	$0.022	$1,759	On-market trade
02/12/19	Glenn Smith	Cancelled	14,377,766	$0.055	$790,777	Cancellation of securities
02/12/19	Glenn Smith	Issued	14,377,766	$0.055	$790,777	Issue of options
28/08/19	Jefferson Harcourt	Issued	10,000,000	$0.01	$100,000	Rights issue
28/08/19	Sue MacLeman	Issued	133,098	$0.01	$1,331	Rights issue
28/08/19	Mark Simari	Issued	454,546	$0.01	$4,545	Rights issue
28/08/19	Glenn Smith	Issued	454,546	$0.01	$4,545	Rights issue
28/08/19	Mark Simari	Issued	909,091	$0.01	$9,091	Rights issue
19/06/19	Glenn Smith	Buy	+479,790	$0.018	$8,717	On-market trade
16/04/19	Jefferson Harcourt	Buy	+2,000,000	$0.02	$40,000	On-market trade
25/03/19	Glenn Smith	Buy	+250,000	$0.021	$5,250	On-market trade
04/03/19	Sue MacLeman	Buy	+150,000	$0.026	$3,877	On-market trade
14/12/18	Jefferson Harcourt	Buy	+500,000	$0.03	$15,000	On-market trade
07/12/18	Glenn Smith	Buy	+70,210	$0.029	$2,036	On-market trade
29/10/18	Mark Simari	Buy	+500,000	$0.03	$15,000	On-market trade
23/10/18	Mark Simari	Buy	+500,000	$0.032	$16,000	On-market trade
08/10/18	Glenn Smith	Buy	+200,000	$0.032	$6,400	On-market trade
08/10/18	Sue MacLeman	Issued	142,814	$0.032	$4,570	Issue of options
20/09/18	Jefferson Harcourt	Buy	+500,000	$0.035	$17,500	On-market trade
13/09/18	Sue MacLeman	Buy	+142,814	$0.035	$4,998	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
David Brookes	27/11/2020	200,000	2,800,000	3,400,000	N/A
Glenn Smith	27/11/2020	N/A	1,454,546	22,500,000	N/A
Jefferson Harcourt	30/06/2020	N/A	38,688,423	3,400,000	N/A
Sue MacLeman	30/06/2020	N/A	505,920	6,800,000	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Grey Innovation Holdings Pty Ltd	30,909,488	4.13%
Mondo Electronics Pty Ltd <Mondo Electronics S/F A/C>	21,000,000	2.80%
Moonah Capital Pty Ltd	17,000,000	2.27%
Sailors Of Samui Pty Ltd	14,800,000	1.98%
Mr Donal Francis O'sullivan	11,000,000	1.47%
Ten Goals Pty Ltd <Hamish Mclachlan Family A/C>	10,000,000	1.33%
Puntero Pty Ltd	10,000,000	1.33%
Mrs Shweta Priyadarshini	9,850,000	1.31%
The King's Ransom (Vic) Pty Ltd <King Family Super Fund A/C>	9,223,100	1.23%
Mr John George Thomas & Mrs Angela Thomas	7,480,500	1.00%
TG Sfund Pty Ltd <Tg Superannuation Fund A/C>	7,407,679	0.99%
Mr Carmelo Cannavo	7,320,000	0.98%
Corwest Pty Ltd	6,415,560	0.86%
A C N 154 894 256 <Harcourt Family A/C>	6,333,333	0.85%
Kembla No 20 Pty Ltd <Caa A/C>	6,126,724	0.82%
Citicorp Nominees Pty Limited	6,090,333	0.81%
Citos Super Pty Ltd <Citos Pty Ltd Sf A/C>	6,000,000	0.80%
JMT Investment Group Vic Pty Ltd <John Turner Super Fund A/C>	6,000,000	0.80%
Mr Murray John Turner	6,000,000	0.80%
Crestpond Pty Limited	5,500,000	0.73%
Teefish Super Pty Ltd <Teefish Super Fund A/C>	5,350,000	0.71%
Cvcv Pty Ltd <Cvc Vellios Super Fund A/C>	5,000,000	0.67%
JMT Investment Group Vic Pty Ltd	5,000,000	0.67%
Mr Brett Fielder	4,453,762	0.59%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.025	30 June

TD1 Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.